Product Images Ketorolac Tromethamine

The table provides the approximate average pharmacokinetic parameters for Ketorolac Trometharmine. It shows values for oral, intramuscular, and intravenous doses, including bioavailability, time-to-peak plasma concentration, % dose metabolized, % dose excreted in urine/feces, plasma protein binding, and volume of distribution. The values for single-dose and steady-state are also specified, alongside simulated data.*

This is a table showing the influence of age, liver and kidney function on the clearance and half-life of Ketorolac Tromethamine in adult populations. The data is organized according to type of subjects and the type of administration (oral or intramuscular). The table shows the total clearance and the terminal half-life in liters/hours/kilogram. The table provides means and ranges for each subject group. The data is estimated from single doses of Ketorolac Tromethamine.*

This is a list of possible side effects associated with a medication or a medical condition. The side effects include gastrointestinal issues such as abdominal pain, constipation, diarrhea, dyspepsia, flatulence, fullness, ulcers, gross bleeding/perforation, heartburn, nausea, stomatitis, and vomiting. Other possible experiences include abnormal renal function, anemia, dizziness, drowsiness, edema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating. These side effects have an incidence greater than 10%.*

This is a table showing the incidence of serious gastrointestinal bleeding in patients treated with Ketorolac Tromethamine Injection up to 5 days, based on age, total daily dose, and history of G.I. problems. The data is divided into two sections: one for adult patients with no history of G.I. bleeding, and the other for adult patients with a history of it. The table shows the incidence of bleeding for each category based on the patient's age and the total daily dose of the medication.*

The NDC Number for Ketorolac Tromethamine Injection USP and its package factor is available. The product is available in three variations with different doses in each single-dose vial. The product is packed in 25 vials per carton. The highest dose product is specified for intramuscular use only.*

Description not available. The text appears to be a list of product information including a medication name, lot number, and prescription details.*